Literature DB >> 15180510

Immunotoxins and other conjugates: preparation and general characteristics.

Giulio Fracasso1, Giuseppe Bellisola, Deborah Castelletti, Giuseppe Tridente, Marco Colombatti.   

Abstract

Targeted toxins represent an invaluable tool offering a wide range of potential applications, both in experimental models and in the clinics. Here we will review several aspects related to the preparation and properties of carrier molecule-toxin heteroconjugates and fusion toxins.

Mesh：

Substances：

Year:  2004        PMID： 15180510     DOI： 10.2174/1389557043403909

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  8 in total

1.  Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma.

Authors:  Pilar Puerto-Camacho; Ana Teresa Amaral; Salah-Eddine Lamhamedi-Cherradi; Joseph A Ludwig; Enrique de Álava; Brian A Menegaz; Helena Castillo-Ecija; José Luis Ordóñez; Saioa Domínguez; Carmen Jordan-Perez; Juan Diaz-Martin; Laura Romero-Pérez; Maria Lopez-Alvarez; Gema Civantos-Jubera; María José Robles-Frías; Michele Biscuola; Cristina Ferrer; Jaume Mora; Branko Cuglievan; Keri Schadler; Oliver Seifert; Roland Kontermann; Klaus Pfizenmaier; Laureano Simón; Myriam Fabre; Ángel M Carcaboso
Journal:  Clin Cancer Res       Date:  2018-11-12       Impact factor: 12.531

Review 2.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 3.  Immunotoxins and other conjugates containing saporin-s6 for cancer therapy.

Authors:  Letizia Polito; Massimo Bortolotti; Manuela Pedrazzi; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2011-06-22       Impact factor: 4.546

Review 4.  Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.

Authors:  José M Ferreras; Lucía Citores; Rosario Iglesias; Pilar Jiménez; Tomás Girbés
Journal:  Toxins (Basel)       Date:  2011-04-29       Impact factor: 4.546

Review 5.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

Review 6.  Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview.

Authors:  Letizia Polito; Alice Djemil; Massimo Bortolotti
Journal:  Biomedicines       Date:  2016-06-01

Review 7.  Elderberries: a source of ribosome-inactivating proteins with lectin activity.

Authors:  Jesús Tejero; Pilar Jiménez; Emiliano J Quinto; Damián Cordoba-Diaz; Manuel Garrosa; Manuel Cordoba-Diaz; Manuel J Gayoso; Tomás Girbés
Journal:  Molecules       Date:  2015-01-30       Impact factor: 4.411

Review 8.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.